Skip to content
Clinical Trials – home

Institut für Allergie- und Asthmaforschung Berlin

Verified siteinfo

Germany Hauptstraße 88, 12099 Berlin, Germany

  • Asthma · Chronic obstructive pulmonary disease
  • Adult patients

About Specializations

Institut für Allergie- und Asthmaforschung Berlin in Berlin, Germany specialises in clinical trials of conditions such as Asthma, Chronic obstructive pulmonary disease, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Medicine

The medical center is at the forefront of respiratory medicine, focusing on innovative treatments for asthma and other pulmonary conditions. The center's research is dedicated to improving the quality of life for patients with moderate to severe asthma, adhering to the latest guidelines from the Global Initiative for Asthma (GINA).

  • Asthma Management
  • Bronchoconstriction Prevention
  • Inhalation Therapy Innovations

Through its cutting-edge research, the center is exploring the efficacy and safety of new propellant formulations in inhalation therapies, aiming to reduce bronchoconstriction and enhance patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Hauptstraße 8812099 BerlinGermany
Recruiting now
no trials
Conditions studied
2
Partner status
Verified site

More sites in BerlinGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Asthma

Not recruiting

Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atuliflapon
  • Sponsor:AstraZeneca AB

Asthma

Not recruiting

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.

Asthma

Not recruiting

Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.

Study of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.